AbbVie Financials

ABBV Stock  USD 182.10  1.75  0.97%   
Based on the measurements of operating efficiency obtained from AbbVie's historical financial statements, AbbVie Inc may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At this time, AbbVie's Deferred Long Term Liabilities is fairly stable compared to the past year. Key indicators impacting AbbVie's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.08510.0895
Notably Down
Slightly volatile
Return On Assets0.03430.0361
Notably Down
Slightly volatile
Operating Income9.4 B17.4 B
Way Down
Slightly volatile
Current Ratio1.710.8721
Way Up
Slightly volatile
The financial analysis of AbbVie is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for AbbVie includes many different criteria found on its balance sheet. For example, investors should never minimize AbbVie's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor AbbVie's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in AbbVie.

Net Income

6.33 Billion

With this module, you can analyze AbbVie financials for your investing period. You should be able to track the changes in AbbVie individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past AbbVie Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AbbVie's financial statements are interrelated, with each one affecting the others. For example, an increase in AbbVie's assets may result in an increase in income on the income statement.
Evaluating AbbVie's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of AbbVie's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the AbbVie's relative financial performance

Chance Of Distress

Less than 13

 
100  
 
Zero
Low
AbbVie Inc has less than 13 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for AbbVie stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, AbbVie's odds of distress score SHOULD NOT be confused with the real chance of AbbVie Inc filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as AbbVie is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include AbbVie's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in AbbVie's official financial statements usually reflect AbbVie's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AbbVie Inc. For example, before you start analyzing numbers published by AbbVie accountants, it's critical to develop an understanding of what AbbVie's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of AbbVie's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AbbVie's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AbbVie's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AbbVie Inc. Please utilize our Beneish M Score to check the likelihood of AbbVie's management manipulating its earnings.

AbbVie Company Summary

AbbVie competes with Chevron Corp, McDonalds, Bank of America, Alcoa Corp, and Coca Cola. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.
Foreign Associates
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
CIK Number0001551152
ISINUS00287Y1091
CUSIP00287Y109
RegionNorth America
LocationIllinois; U.S.A
Business Address1 North Waukegan
SectorBiotechnology
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.abbvie.com
Phone847 932 7900
CurrencyUSD - US Dollar
You should never invest in AbbVie without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of AbbVie Stock, because this is throwing your money away. Analyzing the key information contained in AbbVie's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

AbbVie Key Financial Ratios

Generally speaking, AbbVie's financial ratios allow both analysts and investors to convert raw data from AbbVie's financial statements into concise, actionable information that can be used to evaluate the performance of AbbVie over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that AbbVie Inc reports annually and quarterly.

AbbVie Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets89.1B150.6B146.5B138.8B134.7B81.2B
Other Current Liab10.4B17.9B19.8B22.5B30.7B32.2B
Other Liab18.5B30.4B31.0B31.7B36.5B38.3B
Net Debt26.8B77.6B66.9B54.1B46.6B32.2B
Accounts Payable1.5B2.3B2.9B2.9B3.7B3.9B
Cash39.9B8.4B9.7B9.2B12.8B10.5B
Other Assets1.9B5.1B4.1B4.8B5.6B5.8B
Net Receivables5.4B8.8B10.0B11.3B11.2B6.8B
Good Will15.6B33.1B32.4B32.2B32.3B18.6B
Inventory1.8B3.3B3.1B3.6B4.1B2.2B
Total Liab97.3B137.5B131.1B121.5B124.3B74.1B
Total Current Assets49.5B24.2B27.9B28.5B33.0B23.5B
Intangible Assets18.6B82.9B76.0B67.4B55.6B32.2B
Long Term Debt63.0B77.6B64.2B59.1B52.2B41.2B
Short Term Debt3.8B8.5B12.5B4.1B7.2B5.2B
Net Tangible Assets(42.4B)(102.9B)(96.2B)(82.3B)(74.1B)(77.8B)
Retained Earnings4.7B1.1B3.1B4.8B(1B)(950M)
Long Term Debt Total63.0B77.6B64.2B59.1B68.0B50.1B
Capital Surpluse15.2B17.4B18.3B19.2B22.1B15.8B

AbbVie Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what AbbVie's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense1.5B2.3B2.4B2.2B1.7B1.1B
Total Revenue33.3B45.8B56.2B58.1B54.3B33.8B
Gross Profit25.8B30.4B38.8B40.6B45.5B25.2B
Operating Income13.0B476M17.9B18.1B17.4B9.4B
Ebit13.0B476M17.9B18.1B9.4B8.8B
Research Development6.4B6.6B7.1B6.5B7.0B5.4B
Ebitda13.8B6.9B26.4B26.6B18.1B12.0B
Cost Of Revenue7.4B15.4B17.4B17.4B8.8B8.7B
Income Before Tax8.4B3.4B13.0B13.5B6.3B7.3B
Net Income7.9B4.6B11.5B11.8B4.9B6.3B
Income Tax Expense544M(1.2B)1.4B1.6B1.4B996.2M
Non Recurring385M1.2B962M697M801.6M553.6M
Tax Provision544M(1.2B)1.4B1.6B1.4B811.5M
Interest Income275M174M39M186M540M567M
Net Interest Income(1.5B)(2.3B)(2.4B)(2.0B)(1.7B)(1.8B)

AbbVie Key Cash Accounts

Cash flow analysis captures how much money flows into and out of AbbVie Inc. It measures of how well AbbVie is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money AbbVie brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money AbbVie had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what AbbVie has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201920202021202220232024 (projected)
Change To Inventory(231M)(40M)(142M)(686M)(417M)(396.2M)
Change In Cash32.6B(31.5B)1.3B(545M)3.6B3.8B
Free Cash Flow12.8B16.8B22.0B24.2B22.1B12.0B
Depreciation2.0B6.5B8.5B8.5B8.7B9.1B
Other Non Cash Items3.6B8.0B4.2B6.1B8.6B9.0B
Capital Expenditures552M798M787M695M777M611.5M
Net Income7.9B4.6B11.5B11.8B4.9B6.3B
End Period Cash Flow39.9B8.4B9.7B9.2B12.8B9.8B
Investments981M114M(1.4B)(447M)(2.0B)(1.9B)
Change Receivables(74M)(929M)(1.3B)(1.5B)(1.3B)(1.2B)
Net Borrowings25.8B(2.7B)(8.4B)(12.4B)(11.2B)(10.6B)
Dividends Paid6.4B7.7B9.3B10.0B(10.5B)(10.0B)
Change To Netincome4.8B6.4B4.0B2.6B3.0B3.4B

AbbVie Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AbbVie's current stock value. Our valuation model uses many indicators to compare AbbVie value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AbbVie competition to find correlations between indicators driving AbbVie's intrinsic value. More Info.
AbbVie Inc is number one stock in gross profit category among related companies. It is number one stock in book value per share category among related companies . The ratio of Gross Profit to Book Value Per Share for AbbVie Inc is about  7,078,063,746 . At this time, AbbVie's Gross Profit is fairly stable compared to the past year.. Comparative valuation analysis is a catch-all model that can be used if you cannot value AbbVie by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AbbVie's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AbbVie's earnings, one of the primary drivers of an investment's value.

AbbVie Inc Systematic Risk

AbbVie's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. AbbVie volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on AbbVie Inc correlated with the market. If Beta is less than 0 AbbVie generally moves in the opposite direction as compared to the market. If AbbVie Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one AbbVie Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of AbbVie is generally in the same direction as the market. If Beta > 1 AbbVie moves generally in the same direction as, but more than the movement of the benchmark.

About AbbVie Financials

What exactly are AbbVie Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include AbbVie's income statement, its balance sheet, and the statement of cash flows. Potential AbbVie investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although AbbVie investors may use each financial statement separately, they are all related. The changes in AbbVie's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AbbVie's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze AbbVie Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as AbbVie is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of AbbVie has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if AbbVie's financials are consistent with your investment objective using the following steps:
  • Review AbbVie's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand AbbVie's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare AbbVie's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if AbbVie's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

AbbVie Thematic Clasifications

AbbVie Inc is part of several thematic ideas from Giant Impact to Macroaxis Index. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in AbbVie Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AbbVie's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of AbbVie growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.96)

At this time, AbbVie's Price Earnings To Growth Ratio is fairly stable compared to the past year.

AbbVie March 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of AbbVie help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AbbVie Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of AbbVie Inc based on widely used predictive technical indicators. In general, we focus on analyzing AbbVie Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AbbVie's daily price indicators and compare them against related drivers.
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.